Cancel
Rick Kendall
Chief Scientific Officer
@
Catena Biosciences
See Linkedin
About Rick Kendall
Rick Kendall is the Chief Scientific Officer with a PhD from the University of California, Irvine, and a Bachelor's degree from UCLA. He has held leadership roles at ImmPACT BIO, Kite Pharma, and Amgen, contributing to significant advancements in oncology research.
Known information
Rick Kendall serves as the Chief Scientific Officer and holds a PhD from the University of California, Irvine, School of Medicine, along with a Bachelor of Science degree from the University of California, Los Angeles. Prior to his current role, he was the president and CEO of ImmPACT BIO, a cell therapy company. He also served as vice president of research at Kite Pharma and worked as an executive director and head of oncology research at Amgen. Kendall initiated efforts that led to the development of the first true KRAS inhibitor, LUMAKRAS, and led the research diligence and integration team for the Micromet acquisition at Amgen.
About Catena Biosciences
Catena Biosciences, based in Berkeley, CA, specializes in the development of novel biomolecules for targeted cancer therapies using its proprietary CysTyr platform.
Report inaccurate information
